Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

Randomized, controlled, parallel groups, open-label, blinded end-point assessment, multicenter study, comparing the effects of a low glucose peritoneal dialysis solution, XyloCore, to glucose solutions (Physioneal, Fixioneal, Dianeal, Balance, Bicavera, Bicanova or Equibalance) only regimen, in patients with End-Stage Renal Disease (ESRD) receiving Continuous Ambulatory Peritoneal Dialysis (CAPD), over a 6-month study period.

Participants needed: 170
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Iperboreal Pharma SrlUpdated: Mar 24, 2026Locations: 41
Eligibility criteria

Age ≥18 years [+8]

History of drug or alcohol abuse in the six months prior to entering the protoco... [+16]

Status: Recruiting

Peritoneal Ultrafiltration in Cardio Renal Syndrome.

Randomized, controlled, unblinded, adaptive design clinical trial to evaluate the safety and efficacy of PolyCore (Polydextrin, L-Carnitine, D-xylitol) peritoneal ultrafiltration (PUF) in patients with heart failure and reduced ejection fraction (HFrEF).

Participants needed: 84
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Iperboreal Pharma SrlUpdated: May 16, 2025Locations: 3
Eligibility criteria

Age ≥18 yrs [+9]

Recipients of heart transplantation [+23]